Objective To determine whether the development of acute lung injury (ALI) 
Introduction

Acute lung injury (ALI) or acute respiratory distress syndrome (ARDS) is an acute inflammatory lung injury that may be associated with systemic inflammatory response syndrome (SIRS) and develops after a latent period of hours or days subsequent to various predisposing conditions, including multiple trauma, burns, and acute pancreatitis (1, 2). Neutrophils and their products, especially reactive oxygen species and serine proteases such as elastase, are implicated in the pathogenesis of ALI/ARDS (2-5). In fact, neutrophil elastase is elevated in the circulation of ARDS patients (6-8). In addition, it has been reported that sivelestat, a specific elastase inhibitor, is efficacious in a variety of animal models of ALI (4). These findings indicate that elastase could be a therapeutic target for the treatment of ALI/ARDS. However, the clinical trial of sivelestat failed to improve the survival rate of ALI/ARDS, although some beneficial effects such as reduced duration of mechanical ventilation were observed (9-11). In the previous studies, sivelestat was always administered after the development of ALI/ARDS, implying that the lung injury is already established before the administration of sivelestat. The failure of sivelestat to improve the
T a b l e 1 . Ch a r a c t e r i s t i c s o f P a t i e n t s survival rate of ALI/ARDS might be ascribed to the late administration of this inhibitor. The timing of any neutrophil elastase-directed intervention may be critically important for
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F i g u r e 1 . T h e c o n c e n t r a t i o n s o f n e u t r o p h i l e l a s t a s e a n d i n f l a mma t o r y c y t o k i n e s i n t h e c i r c u l a t i o n o f t h e p a t i e n t s wi t h S I RS a l o n e , a n d i n Gr o u p A a n d Gr o u p B o f AL I / ARDS wi t h S I RS . F o r t h e s t a t i s t i c a l a n a l y s i s , a l l s a mp l e s o b t a i n e d wi t h i n 5 d a y s a f t e r t h e o n s e t o f S I RS we r e u s e d f o r S I RS a l o n e a n d Gr o u p A o f AL I / ARDS wi t h S I RS . F o r Gr o u p B o f AL I / ARDS wi t h S I RS , a l l s a mp l e s o b t a i n e d b e f o r e t h e d e v e l o p me n t o f AL I / ARDS we r e u s e d , b e c a u s e t h e i n t e n s i v e t r e a t me n t s , i n c l u d i n g me c h a n i c a l v e n t i l a t i o n , we r e p e r f o r me d f o r t h e s e p a t i e n t s a f t e r t h e d e v e l o p me n t o f AL I / ARDS a n d t h e i n t e n s i v e t r e a t me n t s c o u l d a f f e c t t h e i n f l a mma t o r y p a r a me t e r s . T h e s a me b l o o d s a mp l e s we r e u s e d f o r d e t e r mi n a t i o n o f t h e c o n c e n t r a t i o n s o f n e u t r o p h i l e l a s t a s e a n d c y t o k i n e s . T h e d a t a a r e e x p r e s s e d a s t h e me a n ± S E . * S i g n i f i c a n t l y e l e v a t e d a s c o mp a r e d wi t h h e a l t h y c o n t r o l s ( * p < 0 . 0 5 ) .
# S i g n i f i c a n t l y g r e a t e r a s c o mp a r e d wi t h S I RS a l o n e (
ego, CA) as directed by the manufacturer.
Statistical analysis
The statistical analysis was performed using KruskalWallis test followed by Mann-Whitney test with adjustment of Bonferroni.
Results
The plasma neutrophil elastase level in healthy controls was 43. 7 Fig. 1) , raising the possibility that the imminent development of ALI/ARDS could be predicted by the plasma neutrophil elastase level.
The neutrophil elastase levels in each patient over the study period are shown in Fig. 2 (Fig. 2) . (Fig. 2 and Fig. 3A and B) . 13 patients) , the elastase level of more than 220 ng/ml was detected within 3 days after the accident (Fig. 3D) . Furthermore, in most patients (10 of 13 patients), the neutrophil elastase level reached more than 220 ng/ml concomitantly with the onset of SIRS (Fig. 3E) , and pulmonary dysfunction was observed within 2 days after the detection of an elastase level of more than 220 ng/ml (Fig. 3F) . Some patients (2 of 13 patients) showed more than 220 ng/ml elastase before the onset of SIRS (Fig. 3E) , indicating that SIRS is not necessarily a predisposing condi-
Most patients developed SIRS within 2 days (15 of 18 patients) and pulmonary dysfunction within 3 days (16 of 18 patients) after the accidents
As a result, most patients (11 of 18 patients) developed pulmonary dysfunction within 1 day after the onset of SIRS. It
F i g u r e 2 . T h e p l a s ma n e u t r o p h i l e l a s t a s e l e v e l s i n e a c h p a t i e n t o v e r t h e s t u d y p e r i o d . T h e p l a s ma n e u t r o p h i l e l a s t a s e l e v e l s i n e a c h p a t i e n t b e l o n g i n g t o t h e g r o u p o f S I RS a l o n e , a n d Gr o u p A a n d Gr o u p B o f AL I / ARDS wi t h S I RS a r e s h o wn o v e r t h e s t u d y p e r i o d . I n e a c h s e t , t h e e l a s t a s e l e v e l s a t t h e i n d i c a t e d d a y s a f t e r t h e o n s e t o f S I RS ( L e f t c o l u mn ) a n d t h e i n i t i a l a c c i d e n t ( Ri g h t c o l u mn ) a r e s h o wn , a n d t h e i d e n t i c a l p a t i e n t i s r e p r e s e n t e d b y t h e s a me s y mb o l . Cl o s e d s y mb o l s r e p r e s e n t t h e e l a s t a s e l e v e l s a t t h e d a y s wh e n p u l mo n a r y d y s f u n c t i o n d e v e l o p e d . Cl o s e d s y mb o l s a r e n o t s h o wn f o r s o me p a t i e n t s , i n wh o m b l o o d s a mp l e s a t t h e d a y s o f t h e d e v e l o p me n t o f p u l mo n a r y d y s f u n c t i o n we r e n o t a v a i l a b l e , b e c a u s e p u l mo n a r y d y s f u n c t i o n d e v e l o p e d b e f o r e t h e o n s e t o f S I RS . S h a d e d a r e a r e p r e s e n t s t h e n o r ma l r a n g e o f t h e e l a s t a s e l e v e l . No t e t h a t t h e v e r t i c a l s c a l e o f t h e e l a s t a s e c o n c e n t r a t i o n s i s d i f f e r e n t . should be noted that some patients (4 of 18 patients) developed pulmonary dysfunction before the onset of SIRS (Fig. 3C). These findings indicate that SIRS is not necessarily a predisposing condition for the development of pulmonary dysfunction or ALI/ARDS, and in some patients pulmonary dysfunction precedes the onset of SIRS. In most patients (11 of
F i g u r e 3 . T h e r e l a t i o n s h i p a mo n g t h e i n i t i a l a c c i d e n t , t h e o n s e t o f S I RS , t h e d e v e l o p me n t o f p u l mo n a r y d y s f u n c t i o n , a n d t h e c r i t i c a l e l e v a t i o n o f n e u t r o p h i l e l a s t a s e i n p a t i e n t s wi t h Gr o u p A a n d Gr o u p B o f AL I / ARDS . T h e d a y s r e q u i r e d f o r t h e o n s e t o f S I RS f r o m t h e i n i t i a l a c c i d e n t ( A) , f o r t h e d e v e l o p me n t o f p u l mo n a r y d y s f u n c t i o n f r o m t h e i n i t i a l a c c i d e n t ( B ) , f o r t h e d e v e l o p me n t o f p u l mo n a r y d y s f u n c t i o n f r o m t h e o n s e t o f S I RS ( C) , f o r t h e d e t e c t i o n o f t h e n e u t r o p h i l e l a s t a s e l e v e l o f mo r e t h a n 2 2 0 n g / ml f r o m t h e i n i t i a l a c c i d e n t ( D) , f o r t h e d e t e c t i o n o f t h e n e u t r o p h i l e l a s t a s e l e v e l o f mo r e t h a n 2 2 0 n g / ml f r o m t h e o n s e t o f S I RS ( E ) , a n d f o r t h e d e v e l o p me n t o f p u l mo n a r y d y s f u n c t i o n f r o m t h e d e t e c t i o n o f t h e n e u t r o p h i l e l a s t a s e l e v e l o f mo r e t h a n 2 2 0 n g / ml ( F ) a r e s h o wn . B l o o d s a mp l e s b e f o r e t h e o n s e t o f S I RS we r e a v a i l a b l e i n 2 p a t i e n t s , i n wh o m t h e e l a s t a s e l e v e l wa s g r e a t e r t h a n 2 2 0 n g / ml b e f o r e t h e o n s e t o f S I RS ( E ) .
tion for remarkable elevation of plasma neutrophil elastase. The results depicted in Figs. 2, 3 (12, 13) . In addition, it has been reported that a significant part of active elastase is associated with the plasma membrane on activated neutrophils, which may contribute to the tissue injury in concert with reactive oxygen species (3, 14) . It 
